Voyager Therapeutics Q3'26 Earnings Preview: EPS Estimated at (0.42) USD
Voyager Therapeutics is set to report Q3'26 results on November 10; revenue is estimated at $6.35 million and EPS at (0.42) USD. The release time is unspecified.
VYGR (Voyager Therapeutics, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 6.35 million USD with EPS (earnings per share) anticipated at (0.42) USD. Learn more detai…